Adlai Nortye (ANL) Liabilities and Shareholders Equity (2022 - 2025)

Adlai Nortye (ANL) reported Liabilities and Shareholders Equity of $34.4 million for Q4 2025, down 51.69% year-over-year from $71.3 million in Q4 2024, and down 52.21% on a QoQ basis from $72.0 million in Q2 2025.

Adlai Nortye (ANL) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $34.4 million in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 51.69% year-over-year to $34.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $285.4 million (down 25.23% YoY) and the FY2025 annual result came in at $34.4 million, down 51.69% from the prior year.
  • Liabilities and Shareholders Equity retreated to $34.4 million in Q4 2025 per ANL's latest filing, from $72.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $130.2 million in Q4 2023 and bottomed at $34.4 million in Q4 2025.
  • The 4-year median for Liabilities and Shareholders Equity is $72.3 million (2022), against an average of $81.4 million.
  • The widest annual swing landed in 2023, when Liabilities and Shareholders Equity soared 79.34%; it then tumbled 51.69% in 2025.
  • Tracing ANL's Liabilities and Shareholders Equity over 4 years: stood at $72.6 million in 2022, then surged by 79.34% to $130.2 million in 2023, then sank by 45.26% to $71.3 million in 2024, then sank by 51.69% to $34.4 million in 2025.
  • Per Business Quant, the three latest ANL Liabilities and Shareholders Equity figures stand at $34.4 million (Q4 2025), $72.0 million (Q2 2025), and $71.3 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 14.93 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 37.37 Mn
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 78.88 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 26.48 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 40.87 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - 23.64 Mn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 5.13 Bn
10 Adlai Nortye 23,840.00 -8.03 Mn - 34.43 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 34.43 Mn
Jun 30, 2025 72.05 Mn
Dec 31, 2024 71.27 Mn
Jun 30, 2024 107.68 Mn
Dec 31, 2023 130.19 Mn
Dec 31, 2022 72.59 Mn